Jefferies downgraded Deciphera to Hold from Buy with a price target of $25.60, down from $26, after Ono agreed to acquire Deciphera for $25.60 per share in cash. The firm expects the deal to close by Q3, since Ono’s broad cancer pipeline is synergistic and has no real overlap with Deciphera, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue